The first Cleveland BioLabs trade was made in Q1 2015.
Since then Jim Simons bought shares thirteen more times and sold shares on nine occasions. The investor completely sold their stake between Q1 2020 and Q3 2021.
Avg closing price
Price range
Sold -98.1 Thousand shares
Q3 2021
Avg closing price
$4.09
Price range
$2.74
-
$6.24
Sold 24.9% shares (-32.5 Thousand shares)
Q2 2021
Avg closing price
$5.38
Price range
$4.49
-
$6.95
Sold 21.2% shares (-35.1 Thousand shares)
Q1 2021
Avg closing price
$5.47
Price range
$3.50
-
$9.55
Sold 19.9% shares (-41.1 Thousand shares)
Q4 2020
Avg closing price
$2.85
Price range
$2.00
-
$3.72
Sold 24.3% shares (-66.5 Thousand shares)
Q3 2020
Avg closing price
$2.30
Price range
$1.65
-
$3.27
Sold 5.6% shares (-16.1 Thousand shares)
Q2 2020
Avg closing price
$1.81
Price range
$1.45
-
$4.26
Sold 6.8% shares (-21.2 Thousand shares)
Q1 2020
Avg closing price
$2.04
Price range
$0.57
-
$4.23
Increased shares by 1.1% (+3.5 Thousand shares)
Q4 2019
Avg closing price
$0.74
Price range
$0.51
-
$1.02
Increased shares by 1.2% (+3.7 Thousand shares)
Q3 2019
Avg closing price
$1.35
Price range
$1.01
-
$1.57
Increased shares by 3.4% (+9.9 Thousand shares)
Q2 2019
Avg closing price
$1.55
Price range
$1.41
-
$1.70
Increased shares by 2.1% (+6.1 Thousand shares)
Q1 2019
Avg closing price
$1.47
Price range
$1.20
-
$2.04
Increased shares by 1.9% (+5.4 Thousand shares)
Q4 2018
Avg closing price
$1.73
Price range
$1.01
-
$2.08
Increased shares by 4.8% (+12.8 Thousand shares)
Q3 2018
Avg closing price
$2.15
Price range
$1.77
-
$2.58
Increased shares by 3.7% (+9.5 Thousand shares)
Q2 2018
Avg closing price
$2.78
Price range
$2.45
-
$3.18
Increased shares by 7.7% (+18.6 Thousand shares)
Q1 2018
Avg closing price
$3.52
Price range
$3.07
-
$4.15
Increased shares by 11.1% (+24 Thousand shares)
Q4 2017
Avg closing price
$3.04
Price range
$2.26
-
$4.10
Increased shares by 12.6% (+24.3 Thousand shares)
Q3 2017
Avg closing price
$2.83
Price range
$2.41
-
$3.46
Increased shares by 450.4% (+158 Thousand shares)
Q2 2017
Avg closing price
$3.27
Price range
$1.50
-
$5.10
Increased shares by 193.9% (+23.1 Thousand shares)
Q1 2017